Biorestorative TherapiesBRTX
13F holders, Q1 2025 (March 31)14holders −1
0new positions
1sold out
$1.78avg. 13F price*
At the end of Q1 2025, 14 institutions reported holding Biorestorative Therapies Inc. (BRTX) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were Geode Capital Management, LLC ($107K), StoneX Group Inc. ($91K) and Wealth Alliance, LLC ($71K).
- Company
- Biorestorative Therapies Inc.
- CUSIP
- 090655606
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $31K |
All 13F filers, Q4 2024 → Q1 2025: 27,718 shares bought and 29,432 shares sold, net −1,714 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Geode Capital Management, LLC | 0.00% | Add +9.6% | 59,997 | $107K |
| StoneX Group Inc. | 0.01% | Add +2.1% | 51,192 | $91K |
| Wealth Alliance, LLC | 0.01% | No change | 40,000 | $71K |
| Morgan Stanley | 0.00% | Add +38.2% | 38,000 | $68K |
| Vanguard Group Inc. | 0.00% | Add +45.2% | 29,730 | $53K |
| State Street Corp. | 0.00% | No change | 20,459 | $36K |
| US Financial Advisors, LLC | 0.01% | No change | 17,142 | $31K |
| Newman Dignan & Sheerar, Inc. | 0.01% | No change | 11,522 | $21K |
| UBS Group AG | 0.00% | Reduce -48.8% | 8,346 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +102.7% | 3,197 | $6K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,193 | $4K |
| SBI Securities Co., Ltd. | 0.00% | Add +23.3% | 74 | $132 |
| Bank of America Corp. | 0.00% | Add +2.4% | 43 | $77 |
| TD Waterhouse Canada Inc. | 0.00% | Add +50.0% | 3 | $5 |
"% of holder's portfolio" is BRTX's weight in each manager's 13F, not the share of Biorestorative Therapies Inc. the manager owns.